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Abstract: Extracts of Sutherlandia frutescens (cancer bush) exhibit considerable qualitative and
quantitative chemical variability depending on their natural wild origins. The purpose of this
study was thus to determine bioactivity of extracts from different regions using in vitro antioxidant
and anti-cancer assays. Extracts of the species are complex and are predominantly composed
of a species-specific set of triterpene saponins (cycloartanol glycosides), the sutherlandiosides,
and flavonoids (quercetin and kaempferol glycosides), the sutherlandins. For the Folin-Ciocalteu
phenolics test values of 93.311 to 125.330 mg GAE/g DE were obtained. The flavonoids ranged
from 54.831 to 66.073 mg CE/g DE using the aluminum chloride assay. Extracts from different sites
were also assayed using the 2,2-diphenyl-1-picrylhydrazyl (DPPH•) radical scavenging method and
ferric reducing anti-oxidant power (FRAP) methods. This was followed by an in vitro Cell Titer-Glo
viability assay of various ecotypes using the DLD-1 colon cancer cell line. All test extracts displayed
anti-oxidant activity through the DPPH• radical scavenging mechanism, with IC50 values ranging
from 3.171 to 7.707 µg·mL−1. However, the degree of anti-oxidant effects differed on a chemotypic
basis with coastal plants from Gansbaai and Pearly Beach (Western Cape) exhibiting superior activity
whereas the Victoria West inland group from the Northern Cape, consistently showed the weakest
anti-oxidant activity for both the DPPH• and FRAP methods. All extracts showed cytotoxicity
on DLD-1 colon cancer cells at the test concentration of 200 µg·mL−1 but Sutherlandia plants from
Colesburg (Northern Cape) exhibited the highest anti-cancer activity. These findings confirm that
S. frutescens specimens display variability in their bioactive capacities based on their natural location,
illustrating the importance of choosing relevant ecotypes for medicinal purposes.
Keywords: cycloartane glycoside; flavonoids; LC-MS; metabolite profiling; terpene saponins;
sutherlandioside; sutherlandin; cancer bush
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1. Introduction
Sutherlandia frutescens (L.) (=Lessertia frutescens (L.) R.Br. (Fabaceae) has a complex chemistry that
contains a unique set of flavonoids and triterpene saponins amongst other chemical constituents [1].
Flavonoids, a phytochemical group of polyphenolic compounds, are recognized for health benefiting
effects exhibiting a diverse range of biological activities such as anti-oxidant, anti-inflammatory,
antimicrobial, anti-tumoral, anti-thrombogenic, anti-therosclerotic, anti-viral, and anti-allergic
properties; to name a few (for details refer to Umesh et al. [2]). They are some of the most effective
anti-oxidant compounds available to humans. They exert their anti-oxidant effect by scavenging oxygen
derived free radicals which are known to have adverse effects on health that lead to the development
of various degenerative diseases such as cancers, brain dysfunction, cardiovascular diseases, and also,
those that are associated with a weakened immune system [2]. The polyphenols, in general, act by
inhibiting or delaying the initiation of oxidative chain reactions. Therefore, the presence of flavonoids
creates more stable and less reactive radicals when the hydroxyl group in these phytochemicals have
reacted and been oxidized by radicals themselves [3]. Flavonoids are also known to exhibit anti-oxidant
action by chelating iron which causes peroxidation when combined with reactive oxygen species [2].
These phytochemical constituents also directly inhibit lipid peroxidation that affects the integrity
of lipid membranes of cells, which is another measure for protection from the adverse effects of
oxidation [2,3]. The production of anti-oxidants in plants is ubiquitous in nature, but those plants with
specialized metabolites that are species specific, may have better anti-oxidant effects than other species.
Triterpene saponins have in the recent decade become very interesting as drug candidates for
cancer chemotherapy due to their cytotoxic and cytostatic effects. The work of Thakur et al. [4] reviews
the potential of these chemicals as anti-cancer agents as triterpene saponins may exhibit their action
by either slowing the growth of tumor cells or result in cell death. These actions are linked to the
permeabilization of membranes, alterations to cellular anion channel function, mitochondrial and
endoplasmic reticulum (ER) malfunction, and stimulation of immune responses in the presence of
carcinogens [4]. Furthermore, they may protect DNA from damage and thus act as anti-mutagens.
As a result, plants with unique triterpenoidal saponins are highly sought after as potential sources of
new anti-tumorigenic drugs.
Scientific interest in S. frutescens is also on the rise as its extracts have been shown to exhibit
anti-cancer activity in in vitro assays. It is important to recognize that, at this stage, our knowledge on
the phytochemical composition of S. frutescens is still shallow as not all metabolites that are synthesized
by this species have been completely elucidated. Progress in this regard dates back to the late 1960s
when triterpene saponins in S. frutescens were first reported [1], but it was only in the past decade,
that chemical biomarkers were purified (refer to Supplementary information for chemical structures).
Specifically, the triterpene saponins of Sutherlandia, (as it is often called in colloquial terms) are in
fact cycloartane glycosides, termed sutherlandiosides (Figure S1). These are characteristic of the
species and they are known to show site-specific variation [5]. They are nowadays used in quality
control protocols as part of the regulatory measures in a commercial production pipeline [5]. Thus far,
the flavonoids that have been characterized in S. frutescens are those with a kaempferol or quercetin
aglycone (Figure S2) and these flavonoid glycosides are also thought to be important contributors
to the various pharmacological activities of the species. Since the bioactivity of medicinal plants is
ascribed to the presence of chemical compounds contained by the plant, the chemotypic variation of
S. frutescens (shown by Albrecht et al. [5] and Zonyane et al. [6] in previous work) might cause variable
bioactivity of plants collected from differing wild habitats. There is a link between strong anti-oxidant
activity and chemopreventative anti-tumor actions mediated by herbal products but the efficacy of the
herbal preparation is often determined by the quality and source of the plant [5].
Although the functional relevance of sutherlandins and sutherlandiosides in the plant is not yet
known, plants in general, are phenotypically plastic, responding to micro-environmental changes by
adjusting metabolic flux leading to chemical-based variation [6]. S. frutescens is widely distributed in
South Africa, occurring in different biomes and where it is found, it is an important herbal medicine that
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is used by various cultural groups and its record of use spans across centuries [1]. The plant is popular
for the treatment of a wide range of ailments including stomach diseases, stress, fever, wounds, diabetes,
and cancers, hence, the Afrikaans name of ‘kankerbos’ or cancer bush in English [1]. Because this
species has a strong reputation in folklore as a medicinal plant that treats cancers, studies to validate
these claims are plenty. For example, some studies showed that extracts lead to apoptosis of breast
cancer cell lines with MCF-7 tumor cells being more susceptible to cell death in comparison to
the MCF-12 A cells [7,8]. They also inhibit growth of CaCo2 colon cancer cells by disrupting cell
membranes and cell death is mediated via the P13-K pathway [9]. Various publications also indicate
the anti-oxidant properties of S. frutescens [10–13] but at this stage, the key bioactive(s) that may hold
anti-cancer activity are not yet known. Furthermore, there is limited information regarding specific
ecotypes and their anti-cancer activities. Most studies typically use material from one chosen natural
population or material that has been farmed but without provenance information being provided in
detail [6]. The latest research shows the cytotoxicity effects of both water and ethanolic extracts of
S. frutescens using a zebrafish bioassay and this effect is clearly dose-dependent [14]. Other recent
studies have tried to explain the mechanisms that may dictate the physiological effects of various
extracts of S. frutescens and the NF-kB, MAPK, and TNF signaling are linked to immune-modulation
effects [15]. Ntuli et al. [16] showed anti-mutagenic effects of ethyl acetate and methanol extracts using
an AMES analysis. Several authors use commercially available products of Sutherlandia to obtain plant
material for pharmacological testing (see work of Leisching et al. [9]; Ntuli et al. [16]; Lin et al., [17];
and Van Der Walt et al. [18]). However, the manufacturers of these products do not necessarily attest
to the origins of the chemotypes used in the manufacturing process and neither do they indicate where
the mother stock plants used for building an agricultural crop of the species actually came from.
To add to a growing body of knowledge with regards to S. frutescens and its chemotypes, the aim
of this particular study was two-fold. At first, it was to establish whether chemical variation among
S. frutescens plants from different places has any implications on anti-oxidant activity of this species
because these plants possess flavonoids and terpene saponins in the form of sutherlandins and
sutherlandiosides, respectively. All other studies focused on using either wild or field-grown plant
material to validate the effects of S. frutescens extracts in bioassays, and in some instances, commercially
purchased leaves without taking into consideration the origins of the plant material have been used as
test materials. The second aim was, therefore, to test for in vitro anti-cancer effects using a DLD-1 colon
cancer cell line which has not been previously tested; and, to establish which of the wild chemotypes
identified by Zonyane et al. [5] showed the greatest potency as accumulation of the sutherlandins and
sutherlandiosides is site specific. This paper thus adds additional evidence to support the popularity
of this medicinal plant as an anti-cancer agent and directly correlates both anti-oxidant and anti-cancer
bioactivities to inter-population based chemical variation.
2. Materials and Methods
2.1. Plant Collection and Extraction
Sutherlandia frutescens plants growing in the wild were collected from various populations
in different provinces of South Africa (Table 1). We targeted the month of November 2014 for
these collections as this is the flowering season. The characteristic orange-red flowers were used
as a diagnostic feature to identify plants in the wild. Most plant material was collected by SZ
(representative voucher numbers: SF (Z14 to 19)) as only one set of samples, from Pearly Beach,
were collected by NPM (NM(1)). A set of voucher specimens was lodged with the herbarium of the
Department of Botany and Zoology (Stellenbosch University, Stellenbosch, South Africa) and during
this time, their botanical identity was confirmed.
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Table 1. Sutherlandia frutescens specimens from different habitats of South Africa and chemical
compounds that are important for their chemotypic differences.
Province Geographic Location
Quercetin and
Kaempferol Derived
Flavonoids
Terpenoid Saponins
(Cycloartanol
Glycosides)
Western Cape
Gansbaai 1
34◦32′09.4”S
19◦24′26.0”E
Sutherlandin B
7.66_755.2021 * 18.69_737.4104 *
Gansbaai 2
34◦32′34.8”S
19◦24′38.6”E
Sutherlandin B
7.66_755.2021 * 18.69_737.4104 *
Pearly Beach
34◦40′47.3”S
19◦33′20.0”E
Sutherlandin B
7.66_755.2021 * 18.69_737.4104 *
Eastern Cape
Burgersdorp
31◦02′26.0”S
25◦44′08.0”E
Sutherlandin A
Sutherlandin B
Sutherlandioside A
Sutherlandioside B
Free State
Zastron
30◦29′49”S
27◦09′71”E
8.73_593.1501 *
7.99_609.1448 *
Sutherlandioside A
Sutherlandioside B
Northern Cape
Colesberg
30◦48′17.3”S
24◦58′52.4”E
Sutherlandin A
Sutherlandin C
Sutherlandin D
Sutherlandioside A
Sutherlandioside B
Victoria West
31◦32′48.2”S
23◦35′00.4”E
Sutherlandin A
Sutherlandin C
Sutherlandin D
Sutherlandioside B
Sutherlandioside C
* Elution time and mass number of unidentified compound.
Plant material was dried at room temperature and stored in the dark for the duration of the
study. Since plants from the same habitats displayed similar LC-MS profiles based on previous
work from our laboratories (see also Zonyane et al. [6], leaf material from four individual plants
from each of the seven localities were pooled together for the anti-oxidant and anti-cancer analyses
(Table 1). One gram of dried and pulverized leaves of S. frutescens was extracted with 20 mL of 75%
(v/v) ethanol and an ultra-sound sonicator (Branson B220H, Danbury; United States of America). for
60 min was used to increase extraction efficiency. The distilled water in the sonicator was kept cool by
the addition of ice during this period. After the extraction, cell debris was removed from the plant
extracts using Whatman® No. 1 filter paper (Merck, Darmstadt, Germany). The filtered extracts were
then concentrated to dryness by evaporating the solvent at room temperature in the dark for 72 h.
Extractions were conducted in triplicate. Each dried extract was weighed and resuspended with 75%
(v/v) ethanol to obtain a stock extract with a concentration of 1 mg·mL−1.
2.2. Measurement of the Total Phenolic and Flavonoid Content
The total phenolic concentration of various S. frutescens plants representing each study collection
site was determined spectrophotometrically by the Folin–Ciocalteu method [19] whereby 50 µL
of the plant extract was mixed with 450 µL of 50% (v/v) methanol and 500 µL of Folin–Ciocalteu
reagent. After 2 min, 2.5 mL of 2% (v/v) sodium carbonate was added to the mixture and the
contents were vortexed to mix thoroughly. The reactions were kept at room temperature in the
dark for 40 min, after which the absorbances were measured at the wavelength of 725 nm with a
UV-Vis spectrophotometer (Thermo Scientific Technologies, Madison, Wisconsin). The total phenolic
content of various Sutherlandia samples was quantified by a calibration curve that was obtained
from absorbance readings of known concentrations of gallic acid standard solutions (2 µg·mL−1 to 16
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µg·mL−1 resuspended in 50% methanol; A = 0.02 c (gallic acid) − 0.0286, R2 = 0.9941). This experiment
was conducted in triplicate. The data were expressed as mg of gallic acid equivalent per grams of dry
extract (mg GAE/g DE).
To determine the total flavonoids content of S. frutescens samples, an aluminum chloride
colorimetric assay was used in which 250 µL of the plant extract was mixed with 1.25 mL of
distilled water and 75 µL of 5% (v/v) sodium nitrite. Samples were left for 5 min before 150 µL
of 10% (v/v) aluminum chloride solution was added. This was followed by addition of 500 µL of
1 M sodium hydroxide solution and 775 µL of distilled water after 5 min. The absorbances were
measured immediately thereafter at 510 nm using a spectrophotometer (Thermo Scientific Technologies,
Madison, WI, USA). The total flavonoid concentration of samples was calculated using the calibration
curve of catechin (10 µg·mL−1 to 500 µg·mL−1 resuspended in 50% methanol; A = 0.0059 c(catechin) +
0.6245, R2 = 0.8592). The assay was conducted in triplicate. The data were calculated to represent mg
of catechin equivalent per gram of dry extract (mg CE/g DE).
2.3. Anti-Oxidant Activity
The anti-oxidant activity was assessed by two methods. The first method involved using the
free radical scavenging method based on the 2,2-diphenyl-1-picrylhydrazyl (DPPH•) assay which
measures the hydrogen donating ability of the plant extract by reducing DPPH• to DPPH-H; and,
this is physically indicated by the bleaching of a purple-colored DPPH• solution. The ferric reducing
anti-oxidant power (FRAP) assay which involves the reduction of a ferric-tripyridyltriazine complex to
its ferrous colored form in the presence of anti-oxidants was also used.
2.3.1. DPPH• Radical Scavenging Activity
To measure the anti-oxidant activity using DPPH• method, 15 µL of the plant extract was mixed
with 735 µL of methanol and 750 µL of 0.1 mM DPPH• solution. The reaction contents were mixed
thoroughly using a vortex and incubated at room temperature for 30 min and covered with aluminum
foil, after which the absorbances of the reaction solutions were measured at the wavelength of 517 nm.
Even though DPPH• is a relatively stable free radical, it gradually deteriorates when it is in solution
form, hence, the assay was conducted under dark conditions and only freshly prepared solutions were
used. An anti-oxidant, ascorbic acid was used as a positive control (0.4 mM to 2.4 mM resuspended in
methanol); A = −0.298c (ascorbic acid) + 0.7482, R2 = 0.9843. The free radical scavenging activity (RSA)
as determined by the decoloration of the DPPH solution was calculated using the following formula:
Scavenging (%) of DPPH = (1 − AE)/AD × 100
where: AE = Absorbance of the reacted extract or antioxidant standard; AD = absorbance of the DPPH
solution only.
A dilution series (1.25, 2.50, 5.00, 10.0, 20.0, and 40 µg·mL−1) for each of the samples from
different sites was prepared to give approximately 0% to 100% inhibition of DPPH•. The radical
scavenging capacity of S. frutescens extracts was then evaluated in terms of their respective IC50 values
(inhibitory concentration of the extract (µg) necessary to neutralize DPPH by 50%) with lower IC50
values indicating higher hydrogen donating (anti-oxidant activity) ability and vice versa.
2.3.2. Ferric Reducing Anti-Oxidant Power (FRAP) Assay
To measure the anti-oxidant activity using the FRAP method, 150 µL of the plant extract was
added to 2850 µL of the FRAP solution which contained 300 mM sodium acetate buffer (pH 3.6), 10 mM
2,4,6-Tri(2-pyridyl)-s-triazine (TPTZ) solution and 20 mM ferric chloride. The reaction contents were
thoroughly mixed and incubated for 30 min at room temperature in the dark. The absorbances were
measured, thereafter, at a wavelength of 593 nm. Trolox (0.1 to 1 mM resuspended in 50% methanol;
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A = 1.8872c (Trolox) + 0.3194, R2 = 0.9631) was used as the standard. The anti-oxidant activity was
expressed as mM Trolox equivalent per gram of dry extract (mM TE/g DE).
2.4. Anti-Cancer Activity
2.4.1. Cell Culture
The anti-proliferative effect of S. frutescens specimens was evaluated on a colon adenocarcinoma
cell line (DLD-1; American Type Culture Collection) as at the time of designing these experiments,
the S. frutescens extract had not previously been tested on this cell line. The DLD-1 cells were provided
by Reaction Biology Corporation where tests were performed (Pennsylvania, USA). The DLD-1 cells
were cultured in 20 µL of RPMI-1640 medium which was supplemented with 10% (v/v) fetal bovine
serum, 100 µg/mL of penicillin and 100 µg/mL of streptomycin. Cultures were maintained at 37 ◦C
in a humidified atmosphere with 5% CO2 (v/v) and 95% air (v/v) and to prevent liquid evaporation
of the medium, a porous microplate sealing film was used to seal the 383-well plate during the cell
incubation period.
2.4.2. Cell Titer-Glo Viability Assay
To conduct the Cell Titer-Glo Viability Assay, the cancer cells were seeded into wells of the 384-well
cell culture plate at 2000 cells per well in triplicate. This was followed by incubation at 37 ◦C in 5%
CO2 overnight to mediate attachment of cells to the wells. Then, each plant extract was added to the
wells of a plate as 5 µL aliquots and the plates were incubated for 48 h for the duration of treatment.
Plant extracts were analyzed in a 10-dose-dependent manner with three-fold serial dilutions and
subsequently, the concentrations that were tested were; 0.01, 0.03, 0.10, 0.30, 0.80, 2.50, 7.40, 22.2, 66.7,
and 200 µg·mL−1 for their cytotoxicity effects on test cancer cells. A protein-kinase inhibitor, 5 µL of
staurosporine (Sigma-Aldrich, Michigan), at the concentration of 10 µM, was used as the reference
compound and was diluted and screened in the same manner as the plant extracts. After 48 h, 25 µL
of CellTiter-Glo® 2.0 luminescent reagent (Promega (Madison, WI, USA)) was added to each well.
The contents were mixed on an orbital shaker for 2 min and incubated at room temperature for 15 min
to stabilize the luminescent signal. Luminescence was recorded by Envision 2104 Multilabel Reader
(PerkinElmer, Santa Clara, CA, USA). The number of viable cells in culture was determined based on
quantitation of the ATP present in each culture well. This assay was performed at Reaction Biology
Corporation (PA, USA).
2.5. Phytochemical Profiling
A Waters Acquity Ultra Performance Liquid Chromatography (Milford, MA, USA) coupled with
an Acquity photo diode array (PDA) detector and a Waters Synapt G2 quadrupole time-of-flight
mass spectrometry was used to analyze phenolic and terpenoid compounds in S. frutescens samples.
Using an autosampler, 1 µL was injected for analysis. The chromatography was performed using
a Waters UPLC BEH C18 column (2.1 mm × 100 mm, 1.7 µm particle size) under a flow rate of 350 µL
min−1 for 26 min. Water (A) and acetonitrile (B) (both containing 0.1% formic acid) were combined
for the elution and the gradient elution was performed as follows: 5% B at 0.5 min, 44% B at 20 min,
100% B at 21 min, 100% B at 22 min, 5% B at 23 min, and A5% B at 26 min. Other conditions were
set at 15 V for the cone voltage, 3.0 kV for the capillary voltage. Data were acquired in MSE mode
and a collision energy of 6 V (low energy transition) to obtain MS data, with a ramp setting of 15
to 60 V for the trap collision energy to obtain fragmentation data. This protocol uses nitrogen as
the desolvation gas (650 L h−1 flow rate and at 275 ◦C) and a positive electrospray ionization mode.
The flavonoids (sutherlandins) and terpenoids (sutherlandiosides) eluted between 6.3–9 min and
15.9–21.6 min, respectively. All spectra of the largest peaks and were tabulated in an excel spreadsheet.
This was followed by combining the mass spectra data, lambda (UV) and fragmentation (MSE) data to
make putative chemical assignments.
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2.6. Data Analysis
All the anti-oxidant data are presented as mean including the standard deviation (mean ±
SD). The results were compared by one-way analysis of variance (ANOVA) to determine significant
differences between the means after normality testing. Differences that are at p < 0.05 between the
means were considered statistically significant. The IC50 values for DPPH reduction were calculated
on GraphPad Prism 7.04, within the dilution series that was prepared.
The in vitro anti-cancer assay results were interpreted in terms of percentage cellular viability
which was expressed as mean ± SD. The Tukey post-hoc test was used to compare which means were
significant from each other at the significance level of p < 0.05. Plant extract concentrations at which
50% cell growth is inhibited (IC50) were determined by the log sigmoid dose-response curve plotted
on GraphPad Prism 4. Data were utilized to construct a principal component analysis illustrated as
a biplot and a Pearson’s correlation matrix was used to visualize relationships between polyphenolic
content, anti-oxidant-, and anti-cancer activities.
3. Results
3.1. Anti-Oxidant Analyses
It is well established that all plants possess anti-oxidant activity but variations in different phenolic
structural profiles lead to different anti-oxidant capacities for plant extracts and extracts of S. frutescens
from different areas were variable (Figure 1).
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Both qualitative and quantitative differences seem to be expressed as a result of geographic
location. Total phenolic content in plants is largely implicated in their anti-oxidant power and ethanol
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extracts of various specimens of S. frutescens obtained from different geographic regions varied in their
composition of total phenolics and flavonoids (Figure 2).Antioxidants 2020, 9, x FOR PEER REVIEW 8 of 19 
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Figure 2. Anti-oxidant effect of Sutherlandia frutescens plants from different localities studied using
in vitro tests. (A) Total phenolic content, (B) Total flavonoid content, (C) comparative DPPH free radical
scavenging activity (IC50) and (D) ferric reducing anti-oxidant power (Trolox equivalent) and IC50curve
for free radical (DPPH•) scavenging activity (E). Mean values (±SD) of triplicate measurements are
presented. Different letters above average bars denote statistically significant differences at p < 0.05.
The co t nt of phenolics ranged from 93.311 to 125.330 mg GAE/g DE with plants from Gansbaai
1 (Western Cape) having the highest concentration followed consecutively by plants from the nearby
region of Pearly Beach (Western Cape) (Figure 2A). Of interest is that, all the Western Cape plants studied
in this particular investigation have been shown to be a chemotype that accumulates sutherlandin
B (Table 1). Sutherlandia plants from Burgersdorp (Eastern Cape) had the lowest value of phenolics
measured (Figure 2A), and predominantly, these plants accumulate the cycloartenol glycosides,
sutherlandioside A and sutherlandioside B (Table 1). The phenolic concentration of plants from the
other wild collection sites were relatively similar and generally significantly lower than the levels of
phenolics that were recorded for Sutherlandia plants from the Western Cape group (p < 0.05) (Figure 2A).
The total flavonoid values are displayed in Figure 2B and flavonoid constituents ranged from 54.831 to
66.073 mg CE/g DE. Sutherlandia plants from Pearly Beach had the highest composition of flavonoids
recorded with the in vitro assay. Similarly, to the phenolic analysis, the levels of flavonoids recorded
for studied specimens followed the same trend with Western Cape having significantly higher amounts
as opposed to those plants from other provinces.
The measurement of the total anti-oxidant phytochemicals was followed by an assessment of the
anti-oxidant capacity of various S. frutescens specimens, shown in Figure 2C,D. As expected, all the
samples from different habitats displayed anti-oxidant activity as demonstrated by both DPPH• and
FRAP assays that were used, and IC50 values ranged between 3.171 and 7.707 µg·mL−1 (Figure 2C).
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The plants from Victoria West displayed an IC50 value of 7.707 µg·mL−1, thereby indicating the lowest
radical scavenging activity recorded among all studied specimens of S. frutescens, whereas those plants
from the Pearly Beach subset had the strongest bioactivity (Figure 2C). Figure 2E shows the IC50 curve
for free radical (DPPH•) scavenging activity and these data further emphasize the higher DPPH• power
of the Gansbaai 1 population group. Both DPPH• and FRAP methods showed a strong correlation
between the total phenolic and flavonoid content and the degree of anti-oxidant activity of Sutherlandia
plants with r2 values of 0.9032 and 0.9163 for radical scavenging activity, respectively, and 0.9501 and
0.9834 for reducing anti-oxidant activity, respectively (Figure 3).
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Again, all S. frutescens specimens from various localities displayed anti-oxidant activity when
they were assessed for reducing anti-oxidant power through FRAP assay. Plants from Gansbaai 1
and Pearly Beach exhibited equal and highest reducing anti-oxidant powers at 16.2319 mM TE/g DE,
followed by plants from Burgerdorp and Colesburg, both with the reducing anti-oxidant powers
at 15.4162 mM TE/g DE (Figure 2D). The two methods, DPPH•, and FRAP assays, used to assess
anti-oxidant activity in this study were more congruent with each other (Figures 2 and 3) and therefore
able to conclusively show those S. frutescens specimens that were more potent in their bioactivities.
Both methods confirmed the presence of variability in the anti-oxidant activities among wild-collected
plants and this was largely correlated to biogeographic zones where plants were harvested from and
those plants from coastal localities being more powerful.
3.2. Anti-Cancer Activity
S. frutescens is reputed as an anti-cancer agent and we were thus interested to examine the
possibilities of variable anti-proliferation effects linked to extracts from disparate habitats. This idea
was based on the fact that there is no consistency and congruency in recorded data as various
laboratories will only collect material from one site to conduct their investigations. The amount of
ATP, as measured by Cell Titer-Glo viability assay was used as a signal for cellular metabolic activity,
therefore, acting as an indirect measure of cell death in extract treated cancer cells. At the highest test
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concentration of 200 µg·mL−1, all tested extracts demonstrated cytotoxicity on test colon cancer cells
(DLD-1).
However, specimens had varying degrees of cytotoxicity on the cancer cells, with plants from
Colesburg (Northern Cape) exhibiting the highest anti-cancer activity (36.6% viability). Even though,
Victoria West is in the Northern Cape (63.2% viability) where some studies have shown plants from
this area to have superior anti-tumor effects [5], these plants were least effective in the anti-cancer
activity test in comparison to extracts produced from other localities (Figure 4). There was no particular
trend connecting the anti-cancer activities with anti-oxidant activities in Section 3.1, except plants
from Gansbaai 1 which showed consistency in their relatively higher anti-oxidant and anti-cancer
activities (Table 2). Between concentrations of 22.2 µg·mL−1 and 200 µg·mL−1, all the plant extracts
induced cytotoxicity on DLD-1 cells in a dose-dependent manner illustrating a relationship regarding
the concentration and cytotoxicity effects where higher concentrations of the extract prevented the
growth of the cancer cells. Concentrations lower than 22.2 µg·mL−1 which ranged from 0.01 µg·mL−1 to
7.4 µg·mL−1 induced similar cytotoxicity on DLD-1 cells (p > 0.05). The IC50 values further confirmed
the relatively higher potency of Colesburg, Zastron and Gansbaai 1 plants as specimens from these
regions had IC50 values of 158.7, 172.7, and 176.7 µg·mL−1, respectively (Table 2).
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Figure 4. The cell viability of DLD-1 colon cancer cell lines treated with Sutherlandia frutescens extracts
at 200 µg·mL−1 from different geographic lo alities u ing an in vitro test. Values are eported as
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Table 2. IC50 values of Sutherlandia frutescens extracts produced from plants growing at different
geographic localities in South Africa.
Plant Type Provincial Location IC50 (µg·mL−1)
Gansbaai 1 Wes ern Cape 176.7
Gansbaai 2 Western Cape >20
Pearly Beach Western Cape >200
Burgersdorp Eastern Cape >200
Zastron Free State 172.7
Colesburg Northern Cape 158.7
Victoria West Northern Cape >200
Boldtype face highlights extracts that are regarded as being active.
3.3. Correlation Matrix and Principal Component Analysis
A Pearson’s correlation matrix was used to reveal the degree of correlation between two parameters,
confirming relationships between the test indices (Figure 5A). As expected, significant positive
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correlations were recorded for total phenolics and flavonoid content (r = 0.916, p = 0.05) but the DPPH
activity was negatively correlated to the flavonoid and total phenolic content (r= −0.847 and r = −0,872
at the p = 0.05 level of significance, respectively). The highest correlation efficient of 0.985 was recorded
for the IC50 values versus the anti-cancer activity and this was also statistically significant.
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Figure 5. Relationship of tested bioactivities from iff t localities (A) Correlation matrix based on
Pearson’s coefficient scores h wing correlated pairs amongst te parameters (p = 0.05). Green i dicates
positive correlations and negative correlations are shown in red and the intensity of the colour
is proportional to the correlation coefficients. (B) Principal component analysis indicating tested
bioactivities and origin of plant extracts of Sutherlandia frutescens. Extracts from different sources are
identified by the locality (represents active observations) and clusters are based on tested attributes of
S. frutescens extracts (represents active variables).
The biplot with resulting PC 1 and PC 2 axes showing principal components corresponding to
68.5% and 22.6% of the variation, respectively, was constructed to further correlate bioactivity and
biogeographic origins of the extracts (Figure 5B). In respect to the overall bioactivity, the biplot shows
the separation of S. frutescens plants, from various regions, into three main clusters. The first cluster
has plants from Colesburg and Zastron which had remarkable high anti-proliferative activity against
DLD-1 cancer cells. On the other hand, the second cluster is composed of S. frutescens plants from
Victoria West, Burgersdorp and Gansbaai 2, characterized by high DPPH IC50 values which signify
relatively low anti-oxidant activity. The S. frutescens plants in the third cluster were from Gansbaai 1
and Pearly Beach and the plants from these regions were mainly characterized by high FRAP activity
and high contents for the presence of flavonoids and phenolics. These plants further had an attribute
of low IC50 values for DPPH activity signifying the high anti-oxidant activity they possessed.
The largest peaks, presented in Figure 1, were used to characterize the profiles of the major
chemicals present in Sutherlandia plants across all populations (Table 3). It is clear that extracts of
S. frutescens are complex with high variation quantitatively in their pool of compounds with anti-oxidant
power. In this study, there are several other kaempferol and quercetin derivatives that were present in
the extracts that have not been fully characterized and remain unknown. The bioactives that have
anti-cancer activity thus need to be explored further. However, it is clear that anti-cancer activity shown
here is not necessarily strongly correlated to the flavonoids. Some of the other chemicals that we were
able to tentatively identify include isomers of the sutherlandins, some triterpenoids and cycloartanol
glycosides (sutherlandiosides). The cycloartanol glycosides have characteristic MS spectra showing
characteristic cycloartanol aglycone fragments (Figure S3), a low double bond equivalency and no UV
peaks [5]. The sutherlandins are flavonols with characteristic UV spectra with a UV max at 265 and 345
nm and also a base peak in the higher energy trace that corresponds to the specific aglycone [M+H],
eg m/z 303.05 for quercetin and m/z 287.055 for kaempferol (Figure S3).
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Table 3. Constituents tentatively identified in Sutherlandia frutescens leaf extracts.
RT (min) [M + H]+ Found MSE Fragment Ions Elemental Formula UV Max Tentative Identity
1 6.31 903.2404 303.051, 465.100,597.142, 771.187 C38H46O25 256; 347
Quercetin glycoside
(Sutherlandin A/B
derivative)
2 6.66 427.1911
149.069, 287.059,
177.07, 120.091,
225.163, 207.126,
163.056, 303.059,
387.197, 427.194
C28H26O4 245; 323 Unknown flavonoid
3 6.80 771.1998 303.051, 609.143,771.198 C33H38O21 256; 347
Quercetin-glycoside
(Sutherlandin A/B
derivative)
4 7.32 741.1874
303.05, 609.144,
741.186, 287.057,
127.041
C32H36O20 256; 352 Sutherlandin A
5 7.54 741.1855 303.05, 609.148,741.19, 187.06, 127.039 C32H36O20 255; 354 Sutherlandin B
6 7.66 755.2021 287.055, 755.200,777.1755 C33H38O20 265; 351
Kaempferol glycoside
(Sutherlandin C/D
derivative)
7 7.99 609.1469 303.051, 609.107,287.059, 187.065 C27H28O16 256; 347
Quercetin glycoside
(Sutherlandin A/B
derivative)
8 8.16 725.1927
287.055, 725.211,
593.146, 303.035,
187.061, 593.148
C32H36O19 264; 347
Sutherlandin C
isomer (small peak)
9 8.32 725.1920
287.055, 593.149,
725.192, 127.039,
187.06
C32H36O19 265; 347 Sutherlandin C
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Table 3. Cont.
RT (min) [M + H]+ Found MSE Fragment Ions Elemental Formula UV Max Tentative Identity
10 8.53 725.1899
287.055, 593.15,
725.191, 127.042,
187.049
C32H36O19 266; 348 Sutherlandin D
11 8.73 593.1501 287.055, 593.1500,615.130 C27H28O15 265,349
Kaempferol glycoside
(Sutherlandin C/D
derivative)
12 9.01 1079.2913
177.056, 303.048,
641.152, 1079.287,
947.248, 145.035
C66H45O15 255; 347
Quercetin glycoside
(Sutherlandin A/B
derivative)
13 9.21 593.1508 287.055, 593.150,615.134 C27H28O15 265; 347
Kaempferol glycoside
(Sutherlandin C/D
derivative)
14 11.79 829.4537
505.348, 487.337,
177.067, 846.464,
851.438
C49H64O11 None
Unknown
triterpenoid
15 12.90 831.4672
505.353, 487.342,
689.387, 203.152,
471.349, 853.458,
705.363
C49H66O11 None
Similar to compound
505 at RT 11.71,
Unknown
triterpenoid
16 15.02 653.4250
473.363, 455.353,
437.342, 491.373,
419.331, 635.416,
653.427, 675.408
C36H60O10 None Sutherlandioside A
17 15.97 813.4630
489.358, 471.347,
651.410, 813.461,
830.489, 835.447
C42H68O15 None
Cycloartanol
glycoside
18 16.31 899.4630
489.358, 471.347,
916.491, 719.400,
657.397, 453.336,
921.447
C45H70O18 None
Unknown
cycloartanol glycoside
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Table 3. Cont.
RT (min) [M + H]+ Found MSE Fragment Ions Elemental Formula UV Max Tentative Identity
19 17.3 653.4252
437.341, 455.352,
419.330, 489.357,
617.404, 635.415,
675.407, 653.424
C36H60O10 None
Sutherlandioside A
isomer
20 17.57 809.4454
489.357, 471.347,
177.06, 437.339,
827.457
C46H65O12 None
Cycloartanol
glycoside
21 17.97 651.4094
489.358, 471.346,
453.336, 668.437,
873.392
C36H58O10 None Sutherlandioside C
22 18.21 825.4257
437.341, 419.331,
455.353, 541.355,
789.407, 771.396,
807.414, 523.343,
842.455, 848.409
C42H65O16 None
Cycloartanol
glycoside
23 18.53 653.4268
437.342, 455.353,
473.363, 489.358,
419.33, 635.416,
653.426, 675.408
C36H60O10 None Sutherlandioside B
24 18.69 737.4104
489.359, 471.348,
453.338, 737.412,
719.401, 657.402,
701.391, 759.395
C39H60O13 None
Cycloartanol
glycoside
25 19.49 635.4160
455.353, 437.342,
419.333, 657.398,
473.364635.419
C36H58O9 None Sutherlandioside D
26 19.99 721.4149
437.341, 455.352,
703.404, 419.330,
685.393, 667.382,
641.407, 721.415,
743.397
C39H60O12 None
Cycloartanol
glycoside
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Table 3. Cont.
RT (min) [M + H]+ Found MSE Fragment Ions Elemental Formula UV Max Tentative Identity
27 20.84 635.4144
437.341, 455.351,
419.330, 657.396,
489.358, 473.362,
635.414
C36H58O9 None
Sutherlandioside D
isomer
28 21.13 721.4154
437.341, 455.352,
721.416, 419.331,
703.404, 473.362,
685.392, 738.443
C39H60O12 None
Cycloartanol
glycoside
29 21.61 703.4058
703.406, 437.342,
455.352, 419.332,
229.160, 685.396
C39H58O11 None
Cycloartanol
glycoside
MSE fragments in boldtype face refers to the base peak (highest peak) [5].
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4. Discussion
The Western Cape samples generally had higher levels of the anti-oxidant phytochemicals
and displayed higher anti-oxidant activities compared to the plants from other provinces within
the Karoo region (Figures 2 and 3). Even though the Western Cape plants performed better than
plants from other provinces, they also had considerable variation among themselves with plants
from Gansbaai 2 consistently being the least active, whereas the plants from the Karoo region had
anti-oxidant phytochemicals (phenolics and flavonoids) that were relatively uniform among each
other (Figure 1A,B). In fact, Karoo specimens have a distinct metabolomic profile that is constituted
of the major triterpene saponin, sutherlandioside B [14]. This is interesting as there has been a
perception, since the isolation and purification of this chemical, that it could play a strong role in the
cytotoxicity actions of Sutherlandia plants and it may have other pharmacological functions, hence it is
monitored in products manufactured from the raw materials of this species [5]). Recently, the study of
Lin et al. [17] showed those fractions with sutherlandioside D to have high anti-tumorogenic effects
against prosrate cancer using an in vivo setup suggesting that these anti-cancer effects are exerted
through Gli/Hn signaling pathways that control cell patterning and formation plus proliferation in
animal cells. A previous study identified a sutherlandioside D isomer in plants obtained from the
Gansbaai area [5] but plants from the Northern Cape had sutherlandioside B and C [6]. These variations
may possibly explain anti-cancer activity exhibited by extracts from different regions.
The present study shows a strong correlation between phenolics and flavonoids and the
anti-oxidant activity, likewise, several studies have demonstrated a positive relationship between total
content of phenolics and respective anti-oxidant capabilities of medicinal plants [20–22]. The plants
referred to here as the Gansbaai 1 and Pearly Beach set possessed the highest concentrations of
phenolics and flavonoids and consequently, these plants displayed the highest radical scavenging
activity and reducing anti-oxidant activity. However, this is inconsistent with the observations linked
to the Burgersdorp chemotype which consistently had the lowest concentrations of both phenolics and
flavonoids, and interestingly, these plants did not turn out to display the lowest anti-oxidant power in
both DPPH• and FRAP methods, applied in this study (Figures 2 and 3).
Despite variations that are site-specific, these data are in agreement with previous reports that
have investigated the anti-oxidant activity of S. frutescens [10–13]. It is important to note that specific
chemotypes have not been directly correlated to their anti-oxidant power in most studies in the past as
their aims have not been placed on studying the bioactivity of plants collected from a range of localities
and biogeographic considerations that may lead to different behaviors of extracts in pharmacological
tests are not the main concern. However, extracts of S. frutescens have been shown to scavenge other
reactive oxygen species that include superoxide ions, hydrogen peroxide, and nitric oxide, which are
known to be involved in the pathogenesis of various health conditions [10,11]. Extracts are also known
to have iron chelating capacity which is an important anti-oxidant feature [13]. It is thus likely that
the anti-oxidant effects are linked to a complex mechanism that has diverse targets. For example,
the suppression of the production of reactive oxygen species in various cell cultures such as neurons
and microglial cells has been demonstrated by Jiang et al. [12] and this plays a protective role against
oxidative stress linked to S. frutescens.
The Karoo (a semi-dessert region) and Western Cape (a coastal region with a Mediterranean
climate) present with different climates that influence plant metabolism, leading to different chemicals
occurring in plant extracts derived from different locations and the work of Zonyane et al. [6] indicate
differential display of sutherlandins and sutherlandiosides for populations found at these localities,
linking the habitat to the geospatial climatic conditions that the plants face. As we had collected the
plants during November to December when the temperatures start to rise and the rain becomes less
frequent in both the Karoo and the Western Cape, this in itself is likely to influence the availability
of bioactives as many other authors discuss the impact of seasons on secondary plant metabolism
is well established. Seasons and plant metabolism show remarkable biochemical adjustments to
environmental changes and such changes need to be monitored for S. frutescens in the future.
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The coastal Western Cape plants are subjected to wetter environments during the winter with
rainfall levels being higher than those plants in the Karoo. Both temperature and moisture content are
well known to cause changes to gene expression that modifies the biochemistry of plants at different
degrees within a plant species occurring in a population. Harsher environments where a variety of
stresses may exist lead to the de novo production of various metabolites that are intricately linked to the
stress response allowing plants to adjust as part of their coping mechanisms to counter ROS generated
due to changing external stress stimuli and flavonoids and terpenes, for example, accumulate at high
levels to counter light induced oxidative stress [23]. The regulation of metabolism is central to many
plant developmental processes, underpinning many ways in which plants respond to the environment,
effecting both short-term and long-term changes. In environments such as the Karoo, that have dry
hot summers with high light intensity, plants under such conditions may inherently accumulate more
chemicals that facilitate the coping mechanisms needed to withstand the ROS-mediated reactions.
It is interesting to note that those plants that come from Colesburg (within the Karoo region) had the
highest anti-proliferative activity (lowest IC50 value of 158.7 µg·mL−1) against tested cancer DLD-1
cell line.
This study is important because there is no documentation of anti-oxidant activities of S. frutescens
attached to the collection of plants from varying biogeographical localities. Recorded anti-oxidant
activity is not surprising as this feature is ubiquitous in plants because it leads to coping with a range
of environmental stresses that plants face due to their sessile nature [24]. Those populations that are
face with environmental stresses are prone to produce excessive levels of reactive oxygen species
(ROS) [23,24]. At basal levels, ROS are in fact important for normal plant growth and development.
However, at excessive levels, they react with cellular macromolecules (proteins, lipids, and/or DNA)
causing oxidative stress and interruption of metabolic enzymes and these result to impaired cell
functions [24]. The anti-oxidant potential is variable in plants from species to species and in different
genotypes of the same species plus there is a positive correlation between anti-oxidant potentials in
plants and stress tolerance that is linked to the function of both flavonoids and terpenes. From this set
of experiments, it is clear that the chemotype is in fact an important consideration which should be
aligned with products claiming to have good anti-oxidant power for phytopharmaceutical producers.
The cytotoxicity of S. frutescens on colon cancer cell lines that has been recorded here (Figure 3) is
consistent with previous studies that have demonstrated anti-proliferative effects of S. frutescens on
SNO esophageal [25] and CaCo2 cell lines [9] which are cell lines related to colon cancer. Literature
has also demonstrated the cytotoxicity of S. frutescens derived extracts on other various cancer cell
lines such as breast cancer cell lines [7,8,26,27], leukemia [27], and cervical cancer cell lines [28] and
presence of both flavonoids and terpenoidal saponins in the extracts suggest that these chemicals
may be responsible for the bioactivity [4]. Although chemical variability is exhibited by this species
based on its biogeographic placement (Figure 4), as shown also by another study of Zonyane et al. [6],
S. frutescens shows promise as an anti-cancer agent and influence of site-dependent bioactivity should
be taken into consideration for standardization of active pharmaceutical ingredient, especially when
the intention is to commercialize this type of activity for human consumption.
Differentiation in the biological properties of S. frutescens can also be attributed to variability in
the chemical composition of S. frutescens specimens screened. The biological activities of S. frutescens,
like any medicinal plant, are due to its complex chemical makeup [29,30]. Literature reports the
presence of flavonoids and triterpene, apart from other compounds that are mainly generated via
central (or primary) metabolism such as pinitol, canavanine, and a suite of amino acids [1,5,29].
The presence of these compounds in Sutherlandia is thought to be responsible, individually or in
combination, for the broad-spectrum bioactivity displayed by the plant [5]. In this particular study,
we tentatively identified several chemicals that are prominent in S. frutescens that have not been fully
characterized but they belong to the flavonoid and terpene saponin groups. It is well accepted that both
flavonoids and terpene saponins exhibit their effects in complex ways to combat the establishment and
growth of cancers, inducing the expression of genes that induce apoptosis and interfere with cell cycle
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leading to its arrest [31,32]. Because sutherlandins are kaempferol- and quercetin-derived compounds,
and such flavonoids do not only prevent cancer cell division and growth, but also, they interfere
with cancer cell migration in vivo plus they downregulate gene expression involved in cancer cell
progression [31,32]. With more research a clearer picture is starting to emerge in terms of the anti-cancer
bioactivity of S. frutescens as different cell signaling mechanisms (i.e., inhibition of the Gli/Hh pathway
and p13-kinase pathway), cytochrome-mediated apoptosis, cell cycle arrest, to name a few, are amongst
the mechanisms that are prominent in the cancer inhibition effect [8,9,12,15,16,18]. Triterpenes are
powerful in their free radical scavenging action and affect anti-oxidant enzymes, changing the route to
pathological development inside cells [33] plus flavonoids and terpene saponins affect accumulation of
anti-inflammation proteins [4,31,32]. It is also likely that sutherlandins and sutherlandiosides work in
concert to illicit anti-oxidant and anti-cancer effects; and, that the other phenolic compounds also add
to the synergism making the extracts more potent.
At this stage, it is unclear which chemicals in the extract possess the highest anti-cancer action
although new information related to this aspect is starting to appear in the literature as fractions
with high amounts of sutherlandioside D were recently found to be more potent against prostate
cancer cells [17]. It would thus be interesting to further the tests on pure samples of sutherlandins and
sutherlandioside in terms of their anti-oxidant and anti-cancer inhibition effects. There is considerable
variation in other phenolic compounds that do not necessarily belong to the sutherlandin group,
eluting between 6 and 7 min (Figure 1) that seem to occur in more abundance in the Gansbaai 1
and Pearly Beach populations and this may further explain the grouping of these plants in cluster 3
(Figure 5). However, there is growing evidence of phytochemical variation in S. frutescens plants found
in diverse provinces as attested in related previous studies [5,6,30]. Therefore, variation in chemical
ingredients of this plants is likely to have implications on its pharmacological properties and future
bioactivity studies should strongly take this into account. Intraspecific chemotypic variation in other
plant species is well documented to affect biological activity of plant-derived medicinal preparations,
and for this reason, chemotype selection is a critical step in quality assured and standardized medicinal
plant extracts [30].
Sutherlandia frutescens has been extensively studied for its various biological activities without
consideration of the plant’s heterogeneity of its chemical composition which is likely to have bearing
on efficacy. The findings of this study highlight the importance of quality control of this medicinal
plant as specimens demonstrated variability in their biological activities concerning anti-oxidant and
anti-cancer activities. It is important to note that S. frutescens also has other biological activities in
addition to anti-cancer and anti-oxidant activities, therefore the variability recorded in this study
warrants further investigation on the chemical variants for efficacy in other biological activities that are
associated with this medicinal plant species. A full-scale characterization of the extracts of S. frutescens
is still urgently needed as there are many chemicals that occur in the plant that remain unknown
(Table 3). With aims to utilize extracts of S. frutescens as a potential phytotherapy against cancer,
it becomes more important to choose chemotypes from wild collected materials that exhibit the greatest
biological activity whose chemistry is better defined. Such a study will assist the industry that has
commercialized the extracts of S. frutescens to earmark those chemotypes that have been shown to
possess the most relevant bioactivity.
5. Conclusions
A strong relationship between ecotypes and their respective anti-oxidant and anti-cancer activities,
which is likely due to variable phenolic and flavonoids composition of samples from different areas,
is indicated in this study. Although the anti-oxidant activity could not be used as an indicator of
potency against cancer cells tested, we could pinpoint those samples that illustrated high bioactivities
for both aspects. We thus show the Western Cape plants as being a better source of anti-oxidant material
but the Northern Cape are superior as anti-cancer agents against the tested cell line. This allows
a more informed choice in terms of those elite specimens of S. frutescens that should be tested in the
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future in in vivo studies, to determine whether the data generated herein is reflected in a more clinical
setting. The variable bioactivity confirmed in this study, supports the need to add to already existing
cytotoxicity analysis of S. frutescens but future studies should focus on individual chemotypes to better
understand the influence of different localities on their toxicity profiles. Such information is important
for guiding various industries that manufacture products of this particular species.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-3921/9/2/152/s1,
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Figure S2: Structures of terpenoidal saponins (sutherlandiosides) specific to Sutherlandia frutescens extracts, Figure
S3: Example MS spectra showing the low energy scan below and the high energy scan above, with the typical
sutherlandioside aglycone fragments, m/z 455, 437, 419, 473 and 489 and the M + H (m/z 653), and, M + Na (m/z
657) ions.
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